Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06676930 · ClinicalTrials.gov registry record · NA
Impact of Artificial Intelligence on Trainee Polyp Miss Rates
A NA study of Colonoscopy and Colon Polyps, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06676930: Recruiting NA study of Colonoscopy and Colon Polyps, sponsored by Northwestern University.
NCT06676930 is a NA study of Colonoscopy and Colon Polyps that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 180 participants, below the 493-participant average among 20 other Colonoscopy trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06676930, a NA study of Colonoscopy and Colon Polyps, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Based on prior studies, trainee and practicing gastroenterologists miss pre-cancerous polyps (adenomas and serrated polyps) during colonoscopy. The use of computer-aided detection (CADe) systems, a form of artificial intelligence (AI) has been shown to help identify colorectal lesions for practicing gastroenterologists. However, less is known how AI impacts polyp detection for trainees. The investigators are conducting a tandem colonoscopy study wherein a portion of the colon is examined first by the trainee and then the attending physician. For each procedure, randomization will occur which will determine whether or not the trainee will utilize AI for their examination of the colon. At the end of the study, the investigators will determine whether AI helps trainees miss fewer polyps during colonoscopy. The investigators will also conduct interviews with trainees to understand how AI impacts colonoscopy training.
Primary Outcome
Proportion of neoplastic (adenomas or serrated polyps) missed during trainee inspection
Conditions Studied
Interventions
- DEVICE Colonoscopy With Computer-Aided Detection
- PROCEDURE Colonoscopy without Computer-Aided Detection
Study Locations (1)
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2024-09-10 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT06676930 shows while recruiting
NCT06676930 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 493-participant average among 20 other Colonoscopy trials with a reported enrollment target (63% lower).
The record links to 3 conditions, with Colonoscopy appearing as the primary indexed condition, and to 2 interventions - of which Colonoscopy With Computer-Aided Detection is the first listed.
NCT06676930 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06676930 about?
NCT06676930 is a clinical study titled "Impact of Artificial Intelligence on Trainee Polyp Miss Rates". Based on prior studies, trainee and practicing gastroenterologists miss pre-cancerous polyps (adenomas and serrated polyps) during colonoscopy. The use of computer-aided detection (CADe) systems, a form of artificial intelligence (AI) has been shown to help identify colorectal lesions for practicing...
What is the current status of trial NCT06676930?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-09-10. Estimated completion is 2026-09.
What conditions does trial NCT06676930 study?
This clinical trial studies the following conditions: Colonoscopy, Colon Polyps, Artificial Intelligence (AI).
What interventions are being tested in trial NCT06676930?
The interventions under investigation include: Colonoscopy With Computer-Aided Detection (DEVICE), Colonoscopy without Computer-Aided Detection (PROCEDURE).
Who is sponsoring clinical trial NCT06676930?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06676930 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06676930's enrollment target sits among peer trials
180 14th of 20 higher than 7 of 20 other Colonoscopy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colonoscopy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cold Snare Endoscopic Mucosal Resection Trial
ACTIVE NOT RECRUITING · NA
-
Comparison of Oxygenation and Ventilation With a Novel Nasal Mask Versus Standard of Care During Colonoscopy
COMPLETED · NA
-
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
COMPLETED · NA
-
CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC)
COMPLETED · NA
-
Morning-Only 4 L PEG vs Split Dose Prep for Afternoon Colonoscopies, Endoscopist-Blinded Prospective Study
COMPLETED · NA
-
EGD-assisted Bowel Preparation for Colonoscopy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI